glp 1 meds Patients' Use GLP-1 Drugs for Weight Loss, Benefit Gains GLP-1 Drugs and the Physiology

Macro vascular complications are still the primary cause of death in patients with T2DM.Glucagon like peptide-1 receptor agonists (GLP1-RAs) are a new class of Injectable Anti-diabetes Agents (IADA) that provides blood glucose control with weight reduction ability, systolic blood pressure reduction and a noticeable improvement of lipid profile

2010;299(4):R108290

Exenatide reduces postprandial and fasting plasma glucose levels via an insulinotropic effect and via the suppression of plasma glucagon levels in the fasted state [18]

NEP inhibition with sacubitril blunted the ability of GLP-1 to increase cAMP levels in coronary vascular cells in vitro

Pedregosa, F